Start-ups Meet Pharma
Blueprint for Successful Partnership
Together, we power the future of health care
Start-ups Meet Pharma is an open innovation initiative, connecting life science corporations facing specific challenges and promising health start-ups that offer relevant solutions. Over the past four years, more than 30 fruitful collaborations have been forged as a result of our proven match-making methodology.
Establishing key connections is difficult, time-consuming and might feel like swimming in an open sea. Start-ups Meet Pharma filters out the noise: meet the right team at the right time. No equity. No IP involvement. No bureaucracy. No long theory-based training. Instead: customized individual meetings to explore partnerships for each challenge.
Open challenges
Disruptive solutions for early disease idenification and lack of quality of care for systemic lupus erythematosus
| Deadline | 23 Apr '23 |
| Learn more | → |
| Apply now | → |
Development of a non-invasive tool/device for monitoring the health status of the gut microbiome
| Deadline | 23 Apr '23 |
| Learn more | → |
| Apply now | → |
Improving Clinical Decision Support Systems in Inflammatory bowel disease (IBD)
| Deadline | 23 Apr '23 |
| Learn more | → |
| Apply now | → |
Starting a partnership is not easy.
We are here to change that.
100% of the start-ups enrolled explore partnerships in 1-on-1 meetings with relevant corporate teams. 50% start one.
Portable interstitial lung disease (ILD) diagnostic tool to improve its diagnostics and optimize the time of treatment initiation.
| Start-ups with a tailored partnership proposal | 13 |
| Partnership exploration meeting | 8 |
| Partnership started | 1 |
Tools for monitoring loss of muscle, strength and/or physical function, to manage sarcopenia and frailty in the elderly.
| Start-ups with a tailored partnership proposal | 17 |
| Partnership exploration meeting | 6 |
| Partnership started | 2 |
Solutions to encourage continuity in treatment strategy and optimization for post-myocardial infarction patients.
| Start-ups with a tailored partnership proposal | 27 |
| Partnership exploration meeting | 10 |
| Partnership started | 2 |
Our clients return year after year.
Word on the street
At Boehringer Ingelheim we recognise the innovative power of life science start-ups. Start-ups Meet Pharma allowed us to establish a platform to scout the best solutions and to select the best-fitting start-ups to establish a partnership with. Together with the team, we have already identified two start-ups and started to build a collaboration.
Farnaz Marzban
At Takeda, we are passionate to serve better our patients. Start-ups Meet Pharma allows Takeda to share the challenges we are working on currently with the most creative minds in European health tech, and to explore how to partner and co-create new solutions with them. SMP truly benefits our patients, and makes fundamental contribution to the vitality of the European health innovation ecosystem.
Hannes Toivanen
Takeda
Start-ups Meets Pharma was very helpful for us because we were able to participate in excellent workshops, get to know other interesting start-ups and have direct exchange with various pharmaceutical companies. This helped us to better develop our pharma business model, get it validated and get access to actual industry decision-makers.
Alexander Krawinkel
FIMO Health
Start-ups Meet Pharma brought business challenges to start-ups which was a fantastic opportunity for us. We learned a lot about partnering with pharma, and were extremely pleased with the outcome for us, which was a project with a leading pharma company.
Bazil Azmil
Breakthrough Health
Start-ups Meet Pharma is a big chance for the start-up teams to tailor our value proposition based on big player’s needs. We had a lot of fun. We learned a lot, we met people we couldn’t otherwise meet, and finally, we had some good, dedicated time with the pharma representatives on how to work with our technology.
Marko Topalovic
ArtIQ
We were selected by Amgen to design and run a pilot in Greece, which is undoubtedly a game-changing opportunity for us and the first wide industry validation of our solution. Their input helped us take our product to a new level which is essential in our efforts to achieve a successful product market fit.
Konstantinos Saridakis
Collaborate Healthcare